Jensen, Frodi Fridason
Håkansson, Kjell E. J. http://orcid.org/0000-0001-5804-0740
Overgaard Nielsen, Britt
Weinreich, Ulla Møller
Ulrik, Charlotte Suppli
Article History
Received: 15 March 2021
Accepted: 18 May 2021
First Online: 31 May 2021
Declarations
:
: Please refer to the Methods section.
: Not applicable.
: FFJ, BO and UMW have no conflicts of interest to disclose related to the present article. KEJH reports personal fees and/or travel grants from AstraZeneca, Chiesi and TEVA unrelated to the present article. CSU has received personal fess for oral presentations, advisory board meeting etc. from AstraZeneca, Novartis, GSK, Boehringer-Ingelheim, ALK-Abello, Chiesi, Sanofi, MundiPharma, Actelion, Orion Pharma and TEVA outside the present paper.